Works matching DE "SANOFI-Aventis SA"
1
- Patient Care (Online), 2024, p. 1
- Article
2
- Diabetes, Obesity & Metabolism, 2011, v. 13, n. 7, p. 673, doi. 10.1111/j.1463-1326.2011.01421.x
- Article
3
- Prescriber, 2012, v. 23, n. 7, p. 42, doi. 10.1002/psb.896
- Article
4
- Clinical Infectious Diseases, 2010, v. 50, n. 4, p. i
- Article
5
- Clinical Infectious Diseases, 2009, v. 49, n. 4, p. ii
- Article
6
- Clinical Infectious Diseases, 2008, v. 46, n. 9, p. iii
- Article
7
- Clinical Infectious Diseases, 2008, v. 46, n. 8, p. iv
- Article
8
- Clinical Infectious Diseases, 2007, v. 44, n. 12, p. iv
- Article
9
- Clinical Infectious Diseases, 2007, v. 44, n. 9, p. iii
- Article
10
- Clinical Infectious Diseases, 2007, v. 44, n. 9, p. iii
- Article
11
- Clinical Infectious Diseases, 2007, v. 44, n. 9, p. iii
- Article
12
- Clinical Infectious Diseases, 2007, v. 44, n. 4, p. iii
- Article
13
- Clinical Infectious Diseases, 2006, v. 42, n. 8, p. 2
- Article
14
- Clinical Infectious Diseases, 2005, v. 41, n. 3, p. 1
- Article
15
- Clinical Infectious Diseases, 2004, v. 39, n. 9, p. 1
- Article
16
- AUANews, 2014, v. 19, n. 11, p. 1
- Article
17
- Australian Prescriber, 2012, v. 35, n. 6, p. 207, doi. 10.18773/austprescr.2012.088
- Article
18
- Nature, 2007, v. 450, n. 7172, p. 935, doi. 10.1038/450935b
- Article
19
- Nature, 2007, v. 446, n. 7131, p. 15, doi. 10.1038/446015a
- Article
20
- Nature, 2005, v. 437, n. 7059, p. 618, doi. 10.1038/437618a
- Article
21
- Psychiatry (1550-5952), 2009, v. 6, n. 9, p. 10
- Article
22
- Missouri Law Review, 2011, v. 76, n. 3, p. 645
- Article
23
- Formulary, 2009, v. 44, n. 8, p. 223
- Article
24
- Formulary, 2007, v. 42, n. 11, p. 656
- Article
25
- Formulary, 2006, v. 41, n. 6, p. 296
- Article
26
- Formulary, 2005, v. 40, n. 10, p. 322
- Article
27
- Formulary, 2005, v. 40, n. 10, p. 321
- Article
28
- Formulary, 2004, v. 39, n. 12, p. 571
- Article
29
- Drugs in R&D, 2008, v. 9, n. 4, p. 261
- Article
30
- Drugs in R&D, 2003, v. 4, n. 6, p. 380
- Limited, Adis International
- Article
31
- Drugs in R&D, 2003, v. 4, n. 6, p. 386
- Limited, Adis International
- Article
32
- JAMA: Journal of the American Medical Association, 2007, v. 297, n. 20, p. 2185, doi. 10.1001/jama.297.20.2185
- Article
33
- Applied Clinical Trials, 2006, v. 15, n. 1, p. 58
- Article
34
- Applied Clinical Trials, 2005, v. 14, n. 4, p. 18
- Article
38
- Australian Journal of Pharmacy, 2011, v. 92, n. 1097, p. 58
- Article
39
- Australian Journal of Pharmacy, 2011, v. 92, n. 1095, p. 48
- Article
40
- Transactions of the Royal Society of Tropical Medicine & Hygiene, 2014, v. 108, n. 10, p. 597, doi. 10.1093/trstmh/tru149
- Thiry, Georges;
- Hombach, Joachim;
- Constenla, Dagna;
- Carvalho, Ana;
- Durbin, Anna
- Article
41
- Contemporary Pediatrics, 2008, v. 25, n. 10, p. 19
- Article
42
- Journal of Generic Medicines, 2011, v. 8, n. 2, p. 117, doi. 10.1177/1741134311413530
- Milchior, R;
- Charbonnel, S;
- Benattar, E
- Article
43
- Brown University Psychopharmacology Update, 2005, v. 16, n. 11, p. 8
- Article
44
- Canadian Veterinary Journal / Revue Vétérinaire Canadienne, 2016, v. 57, n. 10, p. 1100
- Article
45
- Diabetic Medicine, 2007, v. 24, n. 8, p. i, doi. 10.1111/j.1464-5491.2007.02246.x
- Article
46
- Canadian Pharmacists Journal, 2011, v. 144, n. 4, p. 162, doi. 10.3821/1913-701X-144.4.162
- Article
47
- Allergy, 2011, v. 66, n. 11, p. 1503, doi. 10.1111/j.1398-9995.2011.02688.x
- Monteagudo-Paz, A.;
- Salvador, J. S.;
- Martinez, N. L.;
- Granados, P. A.;
- Martínez, P. S.
- Article
48
- Chemistry & Industry, 2011, n. 15, p. 14
- Article
49
- Chemistry & Industry, 2010, n. 11, p. 13
- Article
50
- Chemistry & Industry, 2010, n. 8, p. 12
- Article